XML 69 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Cash Flows [Abstract]    
Net income (loss) $ (13,928) $ 1,318
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 31,598 28,509
Goodwill impairment 6,689 0
Amortization of debt discounts 1,633 1,513
Amortization of debt issuance costs 833 902
Share-based compensation 2,259 2,719
Deferred income taxes (6,517) (10)
Equity in losses of investment 20 40
Unrealized gain on derivative contracts, net (601) (829)
Unrealized foreign currency (gain) loss 9,237 (1,128)
Changes in operating assets and liabilities:    
Accounts receivable, net (25,375) (22,584)
Income tax receivable (17,033) (2,370)
Other current assets (5,475) (13,129)
Accounts payable and accrued liabilities 15,543 (15,899)
Other, net 16,105 13,298
Net cash used in operating activities (17,222) (34,246)
Cash flows from investing activities:    
Capital expenditures (12,389) (11,655)
Proceeds from sale of assets 0 25
Other 0 326
Net cash used in investing activities (12,389) (11,956)
Cash flows from financing activities:    
Repayment of term loans (875) (936)
Repayment of Nordea Q5000 Loan (8,929) (8,929)
Repayment of MARAD Debt (3,556) (3,387)
Debt issuance costs (212) (113)
Payments related to tax withholding for share-based compensation (5,150) (826)
Proceeds from issuance of ESPP shares 331 136
Net cash used in financing activities (18,391) (14,055)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (2,834) 821
Net decrease in cash and cash equivalents and restricted cash (50,836) (59,436)
Cash and cash equivalents and restricted cash:    
Balance, beginning of year 262,561 279,459
Balance, end of period $ 211,725 $ 220,023